ADMA Biologics Inc
NASDAQ:ADMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
Wall St Price Targets
ADMA Price Targets Summary
ADMA Biologics Inc
According to Wall Street analysts, the average 1-year price target for ADMA is 17.09 USD with a low forecast of 12.12 USD and a high forecast of 21 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADMA's stock price target?
Price Target
17.09
USD
According to Wall Street analysts, the average 1-year price target for ADMA is 17.09 USD with a low forecast of 12.12 USD and a high forecast of 21 USD.
What is the Revenue forecast for ADMA Biologics Inc?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 60%. The projected CAGR for the next 3 years is 18%.
What is the Gross Profit forecast for ADMA Biologics Inc?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 66%. The projected CAGR for the next 3 years is 24%.
What is the Operating Income forecast for ADMA Biologics Inc?
Projected CAGR
32%
The compound annual growth rate for Operating Income over the next 3 years is 32%.
What is the Pre-Tax Income forecast for ADMA Biologics Inc?
Projected CAGR
34%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 34%.
What is the Net Income forecast for ADMA Biologics Inc?
Projected CAGR
32%
The compound annual growth rate for Net Income over the next 3 years is 32%.
